Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours Β· Estimated delivery Aug 27 - Sep 1
The effects typically peak during dose escalation phases and improve substantially once patients reach stable maintenance doses
Therefore, the increasing rates of obesity and related metabolic disorders are fueling the GLP-1 receptor agonist market growth
January 2026 milestone: The FDA approved an oral formulation of Wegovy (semaglutide) for chronic weight management in December 2025 the first GLP-1 pill ever approved for obesity treatment
51 PouliouF.PerperopoulouF.LabrouN
GLP-1 hormones naturally follow a daily pattern, peaking during the day and dropping at night
US$ 26.41
US$ 24.04
US$ 28.34
![OP-01] Sleeved Booster Pack](https://jandptcg.com/cdn/shop/files/OP-01.png?v=1767008788&width=3840)